Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mymd Pharmaceuticals Inc MYMD

Healthcare
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro... see more

Recent & Breaking News (NDAQ:MYMD)

Akers Biosciences Issued European Patent Protection for Breath Ketone Detector

Marketwired November 10, 2016

Akers Biosciences Announces Conference Call to Discuss Q3 2016 Earnings

Marketwired November 9, 2016

Akers Biosciences Completes Study on First Rapid Breath Test for Oxidative Stress

Marketwired August 18, 2016

Akers Biosciences Announces H1 and Q2 2016 Earnings

Marketwired August 11, 2016

Akers Biosciences Announces Conference Call to Discuss Q2 2016 Earnings

Marketwired August 9, 2016

Mid-Afternoon Market Update: Crude Oil Down 3.5%; Barclays Shares Tumble

Benzinga.com  June 27, 2016

Mid-Day Market Update: Dow Tumbles 275 Points; Suffolk Bancorp Shares Surge Following Acquisition News

Benzinga.com  June 27, 2016

Akers Biosciences to Present at LD Micro Invitational Conference

Marketwired June 3, 2016

Akers Biosciences Reports Earnings for Q1 2016

Marketwired May 12, 2016

Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings

Marketwired May 10, 2016

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference

Marketwired May 4, 2016

Akers Board Rearrangement

Marketwired April 29, 2016

Akers Biosciences Reports Earnings for Fiscal Year 2015

Marketwired March 30, 2016

Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection

Marketwired March 23, 2016

Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings

Marketwired March 16, 2016

Akers Biosciences Announces $2.5M Order to Supply PIFA Heparin/PF4 Products to China

Marketwired March 2, 2016

Akers Biosciences Hires Leading Commercial Executives to Support Sales Growth

Marketwired February 29, 2016

Akers Biosciences to Present at Disruptive Growth & Healthcare Conference

GlobeNewswire February 8, 2016

Akers Biosciences Updates on Joint Venture in China

GlobeNewswire December 1, 2015

Akers Biosciences to Present at 8th Annual LD Micro Investor Conference

GlobeNewswire November 30, 2015